Acura Pharmaceuticals Inc. (NASDAQ:ACUR)
CAPS Rating:
A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.
A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
No thanks.
The car is nice.
"The car is nice" ?? Explain please.
ACUR is showing some real promise. Why do you disagree?
On 2/27/09 it closed down at $6.32. I forgot to mention the price in my last reply . . . sorry.